reference/10677698

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10677698

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	2588
issn	1528-0020 0006-4971
issueIdentifier	13
pageRange	2581-2588
publicationName	Blood
startingPage	2581
bibliographicCitation	Mateos MV, Oriol A, Martínez-López J, Gutiérrez N, Teruel AI, López de la Guía A, López J, Bengoechea E, Pérez M, Polo M, Palomera L, de Arriba F, González Y, Hernández JM, Granell M, Bello JL, Bargay J, Peñalver FJ, Ribera JM, Martín-Mateos ML, García-Sanz R, Lahuerta JJ, Bladé J, San-Miguel JF. Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial. Blood. 2012 Sep 27;120(13):2581–8. doi: 10.1182/blood-2012-05-427815. PMID: 22889759.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb89e8145b43f5f238d743a516c7ffb6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac9da75ebb773400fcfcc1274602635e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a94dd27954f16626d7261f3fc711f55 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_812f3ef3a6481069b37f93878e0966b6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99d7e633fecd2a8e917954c22fd3104e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_051b3e39a923309b3c88821f5f07a836 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1bbd97584cbb86835fa885c9c5147d65 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3beb831c07ecef7f24d1127b92f79525 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82017e7c46472205124a8a8e70a69740 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2ab851ed4220e963b1756a77ce0387e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aac37938a355fdbdc013f19ed1233b0d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_291908a40f0a828453fd82a61ad6f199 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_85cd050cbb57cade42bc1bad3fe89386 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_736912cf34d4bce92c24fd097e399a38 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6804-2221 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58252d565318a4f82050c79aa0183357 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd012c38cb09b112607647d48ea65481 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3be5a71c7a4d0be482a046dd0c39c40 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03bf6316362fcdfe4513d215f8b031e8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eee9ae35f641b229fee069d72c883484 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_335c76e86c9a1ab50f17f149eccb199c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_abe8efaea0e61d3665807be4593582db http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93459e359383b7bdae85a2e31c1d3cf8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77a23d6e2a4856afd804c77c81aa975b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8bbd19bd8fa6ee2910a493b2f9535a25
date	2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/22889759 https://doi.org/10.1182/blood-2012-05-427815
isPartOf	https://portal.issn.org/resource/ISSN/0006-4971 https://portal.issn.org/resource/ISSN/1528-0020 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1243
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial
discusses	http://id.nlm.nih.gov/mesh/M0021267 http://id.nlm.nih.gov/mesh/M0002834 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0018225 http://id.nlm.nih.gov/mesh/M0350110
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009101Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D060046
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D009101Q000401 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D013792Q000008 http://id.nlm.nih.gov/mesh/D017404 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011241Q000008 http://id.nlm.nih.gov/mesh/D009101Q000235 http://id.nlm.nih.gov/mesh/D001897Q000008 http://id.nlm.nih.gov/mesh/D011719Q000008 http://id.nlm.nih.gov/mesh/D000069286 http://id.nlm.nih.gov/mesh/D012074 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D002869
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460612 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7277 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8561 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8854 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID387447

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243055978 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129356432 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 82.